Requirement for Akt-mediated survival in cell transformation by the dbl oncogene

S Morley1, J Wagner, K Kauppinen

  • 1Division of Nutritional Sciences, Cornell University, Ithaca, NY 14853, USA.

Cellular Signalling
|August 19, 2006
PubMed

Insights

The Dbl oncogene activates cell proliferation signals. This study reveals Dbl utilizes PI3-kinase/Akt pathways to inhibit apoptosis, promoting cell transformation.

Area of Science:

  • Oncogenic signaling pathways
  • Cellular transformation mechanisms
  • Signal transduction in cancer

Background:

  • The Dbl oncogene activates Cdc42, Rac, and Rho GTPases, transducing proliferative signals.
  • Mechanisms integrating Dbl-induced signals and their role in cell transformation are unclear.
  • The involvement of PI3-kinase and Akt in Dbl-mediated transformation requires investigation.

Purpose of the Study:

  • To investigate the role of PI3-kinase and Akt in Dbl-induced cell transformation.
  • To elucidate the signaling pathways linking Dbl to cell survival and proliferation.
  • To identify novel survival complexes formed downstream of Dbl signaling.

Main Methods:

  • Investigated Akt phosphorylation at threonine 308 in Dbl-expressing cells.
  • Utilized pharmacological and biochemical methods to interfere with the PI3-kinase/Akt pathway.
  • Examined the interaction between activated Cdc42 and PDK1.
  • Assessed apoptosis levels and Bad phosphorylation in response to Dbl expression.

Main Results:

  • Dbl induced PI3-kinase-dependent Akt phosphorylation via Rac and Cdc42.
  • Inhibition of this pathway markedly reduced Dbl-induced focus formation.
  • Dbl expression decreased apoptosis and increased Bad phosphorylation.
  • Activated Cdc42 formed complexes with PDK1, a PI3-kinase effector.

Conclusions:

  • Dbl signaling activates the PI3-kinase/Akt pathway, contributing to cell transformation.
  • This pathway generates anti-apoptotic signals, promoting cell survival.
  • Dbl signaling facilitates the formation of a novel survival complex involving Cdc42 and PDK1.

Related Concept Videos

Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
DNA Damage can Stall the Cell Cycle02:36

DNA Damage can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
DNA Damage Can Stall the Cell Cycle02:36

DNA Damage Can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...